Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seung Woo Chung

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Drug Delivery and Translational Research|August 5, 2021
Overcoming physical stromal barriers to cancer immunotherapySeung Woo Chung, Yunxuan Xie, Jung Soo Suk
Journal of Drug Targeting|May 29, 2012
Strategies for non-invasive delivery of biologicsSeung Woo Chung, Taslim A Hil-lal, Youngro Byun
International Journal of Pharmaceutics|January 10, 2012
Paclitaxel loaded nano-aggregates based on pH sensitive polyaspartamide amphiphilic graft copolymersKwangwon Seo, Seung Woo Chung, Youngro Byun, et al.
Pharmaceutical Research|January 15, 2015
Enhanced Anti-Angiogenic Effect of Low Molecular Weight Heparin-Bile Acid Conjugates by Co-Administration of a Selective COX-2 InhibitorJi-Young Kim, Seung Woo Chung, Sang Yoon Kim, et al.
Molecular Biology of the Cell|August 18, 2021
Keratin 19 interacts with GSK3β to regulate its nuclear accumulation and degradation of cyclin D3Pooja Sharma, Sarah Tiufekchiev, Victoria Lising, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 29, 2014
Reduced graphene oxide nanosheets coated with an anti-angiogenic anticancer low-molecular-weight heparin derivative for delivery of anticancer drugsGayong Shim, Ji-Young Kim, Jeonghoon Han, et al.
Journal of Applied Toxicology : JAT|February 18, 2014
Preliminary safety evaluation of a taurocholate-conjugated low-molecular-weight heparin derivative (LHT7): a potent angiogenesis inhibitorFarzana Alam, Seung Woo Chung, Seung Rim Hwang, et al.
Biomaterials|November 18, 2018
Highly potent monomethyl auristatin E prodrug activated by caspase-3 for the chemoradiotherapy of triple-negative breast cancerSeung Woo Chung, Young Seok Cho, Jeong Uk Choi, et al.
Journal of Medicinal Chemistry|August 12, 2015
Optimization of a Stable Linker Involved DEVD Peptide-Doxorubicin Conjugate That Is Activated upon Radiation-Induced Caspase-3-Mediated ApoptosisSeung Woo Chung, Beom Suk Lee, Jeong uk Choi, et al.
Biomaterials|May 13, 2014
Oral delivery of a potent anti-angiogenic heparin conjugate by chemical conjugation and physical complexation using deoxycholic acidFarzana Alam, Taslim A Al-Hilal, Seung Woo Chung, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Drug Delivery and Translational Research|August 5, 2021
Overcoming physical stromal barriers to cancer immunotherapySeung Woo Chung, Yunxuan Xie, Jung Soo Suk
Journal of Drug Targeting|May 29, 2012
Strategies for non-invasive delivery of biologicsSeung Woo Chung, Taslim A Hil-lal, Youngro Byun
International Journal of Pharmaceutics|January 10, 2012
Paclitaxel loaded nano-aggregates based on pH sensitive polyaspartamide amphiphilic graft copolymersKwangwon Seo, Seung Woo Chung, Youngro Byun, et al.
Pharmaceutical Research|January 15, 2015
Enhanced Anti-Angiogenic Effect of Low Molecular Weight Heparin-Bile Acid Conjugates by Co-Administration of a Selective COX-2 InhibitorJi-Young Kim, Seung Woo Chung, Sang Yoon Kim, et al.
Molecular Biology of the Cell|August 18, 2021
Keratin 19 interacts with GSK3β to regulate its nuclear accumulation and degradation of cyclin D3Pooja Sharma, Sarah Tiufekchiev, Victoria Lising, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 29, 2014
Reduced graphene oxide nanosheets coated with an anti-angiogenic anticancer low-molecular-weight heparin derivative for delivery of anticancer drugsGayong Shim, Ji-Young Kim, Jeonghoon Han, et al.
Journal of Applied Toxicology : JAT|February 18, 2014
Preliminary safety evaluation of a taurocholate-conjugated low-molecular-weight heparin derivative (LHT7): a potent angiogenesis inhibitorFarzana Alam, Seung Woo Chung, Seung Rim Hwang, et al.
Biomaterials|November 18, 2018
Highly potent monomethyl auristatin E prodrug activated by caspase-3 for the chemoradiotherapy of triple-negative breast cancerSeung Woo Chung, Young Seok Cho, Jeong Uk Choi, et al.
Journal of Medicinal Chemistry|August 12, 2015
Optimization of a Stable Linker Involved DEVD Peptide-Doxorubicin Conjugate That Is Activated upon Radiation-Induced Caspase-3-Mediated ApoptosisSeung Woo Chung, Beom Suk Lee, Jeong uk Choi, et al.
Biomaterials|May 13, 2014
Oral delivery of a potent anti-angiogenic heparin conjugate by chemical conjugation and physical complexation using deoxycholic acidFarzana Alam, Taslim A Al-Hilal, Seung Woo Chung, et al.
Pageof 5